Static Systems Group is pleased to announce the appointment of Rosie Cunningham Thomas as the company’s new Managing Director, effective 27 July 2021.
Rosie has more than 20 years of strategic and operational leadership in global corporates, SMEs and start-ups. Over the past 12 years, she has specialised in leading and scaling early stage, innovation driven health technology companies through critical growth stages to full commercialisation and clinically evidenced market acceptance.
Rosie has prior Medical CEO experience at Episurf Medical AB, ToHealth Ltd, and FreeHand 2010 Ltd. Prior to her business leadership roles, she held several senior commercial positions at Bard BD and Smiths Industries’ medical division. Most recently, Rosie was the CEO at NuVision Biotherapies, a leading regenerative medicine company which develops life-saving biomaterials.
Discussing her new role, Rosie said: ‘I am delighted to be joining Static Systems Group (SSG) as it starts its next growth phase as part of Halma plc. The Turner family legacy is impressive, and together as SSG, we can honour this legacy whilst building for the future, creating sustainable and lasting value.’
Rosie is a dual UK/US national having emigrated to the UK to marry her English husband. She is a pharmacist and earned a pharmacy degree from the University of the Sciences in Philadelphia and studied business management at the University of Pennsylvania. She will be based out of the SSG facility in Wolverhampton.
For more information, go to www.staticsystems.co.uk
